Abbott Laboratories Price Today
Abbott Laboratories
ABT
Healthcare
$187.20B
💰
Market Cap
32.7
💸
Price to Earnings
$3.3
🎉
EPS
+75
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
13 |
Strong Buy |
8 |
Hold |
8 |
Sell |
0 |
Strong Sell |
0 |
ABT Price Forecast Target
107.7 👉 136.0 +26%
ABT EPS Forecast
3.3 👉 4.6 +40%
Financials
Profit Margin
13 %
Revenue Growth
-11.4 %
Dividend
$ 2.04
Held Percent
0.5% - Insiders
76.4% - Institutions
23.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $16.8B
-
💰 Blackrock Inc. $14.6B
-
💰 Capital Research Global Investors $8.2B
-
💰 State Street Corporation $7.9B
-
💰 Capital International Investors $6.1B
Stock Ideas
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…📮FAQ
Some Frequently Asked Questions.
The Abbott Laboratories industry is Medical Devices
The Abbott Laboratories sector is Healthcare
The Abbott Laboratories forecasted predicted Price to Earnings PE ratio is 23.3
The Abbott Laboratories Price to Earnings PE ratio is 32.7
The Market Capitalization of Abbott Laboratories is $187.20B
There are total of 1722186613 float shares with 76.4% held by Institutions and 0.5% held by insiders
The MAbbott Laboratories forecasted Earnings per Share EPS is $4.6
The Abbott Laboratories Earnings per Share EPS is 3.3
The Abbott Laboratories company has $24579000000 gross profits with 13 profit margins
The Abbott Laboratories Earnings Growth is -0.316% with -0.319% quarterly earnings growth
The Abbott Laboratories Revenue is $40226000896 with -0.114 revenue growth
The price target for Abbott Laboratories stock is $136.0 for the high target and $112.0 for the low target
The consensus analyst recommendations for Abbott Laboratories is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Abbott Laboratories is Buy, with the following breakdown:
- Buy: 13
- Strong Buy: 8
- Hold: 8
- Sell: 0
- Strong Sell: 0
The Beta of Abbott Laboratories is 0.7
The dividend of Abbott Laboratories is $2.04
The dividend yield of Abbott Laboratories is 0.019%
The biggest institutional and mutual fund holders of Abbott Laboratories stock are
- Vanguard Group Inc
- Blackrock Inc.
- Capital Research Global Investors
- State Street Corporation
The Abbott Laboratories ESG Score is 75, with the following breakdown:
- E: 3.03
- S: 13.59
- G: 8.36